CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-23 | Cai Veronica Controller | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2020-01-23 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2020-01-23 | USMAN NASSIM President & CEO | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2020-01-15 | TETLOW SHARON Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-01-15 | Ling Geoffrey M.D. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-01-02 | Williams Eddie Director | Grant or award | +1,743 | 8,839 | ||
| 2020-01-02 | LAWLOR AUGUSTINE Director | Grant or award | +3,166 | 15,608 | ||
| 2019-09-16 | Cai Veronica Controller | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 |
Page 17 of 17 · 328 trades